Pfizer and BioNTech’s Covid-19 vaccine found to be 90% effective
Positive trial results could lead to shot being available for use by the end of the year
Positive trial results could lead to shot being available for use by the end of the year
Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory Approval
The regulatory filing for the vaccine could come as soon as safety data is available, possibly in the third week of November, Pfizer said, lifting the company’s shares and the broader U.S. stock market.
20 Years After Viagra, Pfizer To Develop Another Miracle Drug Amid Budget Cuts